Could targeting a enzyme play a role in slowing lung fibrosis? Boehringer Ingelheim’s research into PDE4B is offering ...

From the 1950s to 1970s, discovery of enzymes began by identifying new chemical reactions within cell-free extracts, but ...

Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of ...

While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting ...

FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...

Encouraging data for CAD-1005 in Phase 2 HIT Study EOP2 scheduled for Q1 for top-priority indication Additional acute and chronic opportunities for 12-LOX inhibition beyond HIT PONTE VEDRA, Fla., ...

Commonly prescribed cardiovascular medications - such as statins, diuretics, and blood pressure drugs - appear to have little ...

Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 study. | Accent Therapeutics has halted work on a solid tumor drug due to adverse events in a phase 1/2 ...

Lynk Pharmaceuticals has reported another phase 3 win in China for its next-gen JAK inhibitor, this time hitting skin clearance goals among patients with eczema. | Lynk Pharmaceuticals has reported ...

Burn Slim is a natural dietary supplement built around one of the most searched weight loss strategies of 2026: the "gelatin ...

Patients taking ACE inhibitors and ARBs saw a 16% reduction in their risk of cancer progression (HR, 0.84; 95% CI, 0.71-0.99; ...

A study was conducted to compare quality of inpatient care between subgroups of Asian patients and non-Hispanic White patients hospitalized for HF.